Precipio Price to Free Cash Flow Ratio 2012-2025 | PRPO
Historical price to free cash flow ratio values for Precipio (PRPO) since 2012.
| Precipio Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-01-23 | 24.55 | 62.15 | |
| 2025-09-30 | 17.79 | $0.40 | 45.04 |
| 2025-06-30 | 11.04 | $0.38 | 29.11 |
| 2025-03-31 | 6.27 | $0.49 | 12.67 |
| 2024-12-31 | 5.54 | $0.15 | 37.58 |
| 2024-09-30 | 6.70 | $-0.36 | 0.00 |
| 2024-06-30 | 5.19 | $-0.68 | 0.00 |
| 2024-03-31 | 6.70 | $-1.93 | 0.00 |
| 2023-12-31 | 6.50 | $-2.84 | 0.00 |
| 2023-09-30 | 5.61 | $-4.06 | 0.00 |
| 2023-06-30 | 7.80 | $-5.76 | 0.00 |
| 2023-03-31 | 13.28 | $-6.34 | 0.00 |
| 2022-12-31 | 11.03 | $-7.03 | 0.00 |
| 2022-09-30 | 16.08 | $-7.47 | 0.00 |
| 2022-06-30 | 21.20 | $-7.31 | 0.00 |
| 2022-03-31 | 27.00 | $-7.33 | 0.00 |
| 2021-12-31 | 31.60 | $-6.88 | 0.00 |
| 2021-09-30 | 56.40 | $-6.66 | 0.00 |
| 2021-06-30 | 72.60 | $-6.02 | 0.00 |
| 2021-03-31 | 46.20 | $-6.90 | 0.00 |
| 2020-12-31 | 41.40 | $-9.14 | 0.00 |
| 2020-09-30 | 49.00 | $-17.06 | 0.00 |
| 2020-06-30 | 28.40 | $-21.20 | 0.00 |
| 2020-03-31 | 14.00 | $-25.21 | 0.00 |
| 2019-12-31 | 41.00 | $-32.29 | 0.00 |
| 2019-09-30 | 52.20 | $-54.96 | 0.00 |
| 2019-06-30 | 67.60 | $-59.62 | 0.00 |
| 2019-03-31 | 37.50 | $-78.58 | 0.00 |
| 2018-12-31 | 46.20 | $-95.09 | 0.00 |
| 2018-09-30 | 118.56 | $-323.76 | 0.00 |
| 2018-06-30 | 110.34 | $-492.97 | 0.00 |
| 2018-03-31 | 161.16 | $-468.38 | 0.00 |
| 2017-12-31 | 360.00 | $-441.66 | 0.00 |
| 2017-09-30 | 648.00 | $-181.56 | 0.00 |
| 2017-06-30 | 2700.00 | $-2.86 | 0.00 |
| 2017-03-31 | 5057.50 | $857.94 | 5.89 |
| 2016-12-31 | 2557.55 | $-2.22 | 0.00 |
| 2016-09-30 | 2537.75 | $-1.79 | 0.00 |
| 2016-06-30 | 4949.51 | $-1.42 | 0.00 |
| 2016-03-31 | 5251.88 | $-861.53 | 0.00 |
| 2015-12-31 | 9629.05 | $-1.02 | 0.00 |
| 2015-09-30 | 8307.97 | $-1.01 | 0.00 |
| 2015-06-30 | 15028.50 | $-1.36 | 0.00 |
| 2015-03-31 | 12958.70 | $-1.69 | 0.00 |
| 2014-12-31 | 18088.20 | $-1.85 | 0.00 |
| 2014-09-30 | 33926.60 | $-1.86 | 0.00 |
| 2014-06-30 | 33656.60 | $-1.43 | 0.00 |
| 2014-03-31 | 41215.90 | $-1.29 | 0.00 |
| 2013-12-31 | 49133.20 | $-1.25 | 0.00 |
| 2013-09-30 | 41034.30 | $-2.73 | 0.00 |
| 2013-06-30 | 43194.00 | $-2.66 | 0.00 |
| 2013-03-31 | 42654.00 | $-2.36 | 0.00 |
| 2012-12-31 | 65870.80 | $-1.91 | 0.00 |
| 2012-09-30 | 102586.00 | $-0.10 | 0.00 |
| 2012-06-30 | 97186.50 | $-0.08 | 0.00 |
| 2012-03-31 | 129582.00 | $-0.05 | 0.00 |
| 2011-12-31 | 139301.00 | $0.00 | 0.00 |
| 2011-09-30 | 139301.00 | $-0.04 | 0.00 |
| 2011-06-30 | 188974.00 | $-0.04 | 0.00 |
| 2011-03-31 | 95026.70 | $-0.05 | 0.00 |
| 2010-12-31 | 71270.00 | $-0.04 | 0.00 |
| 2010-09-30 | 43194.00 | $0.00 | 0.00 |
| 2010-06-30 | 52912.60 | $0.02 | 3226378.05 |
| 2010-03-31 | 92435.10 | $0.02 | 3883827.73 |
| 2009-12-31 | 74509.60 | $0.02 | 4005892.47 |
| 2009-09-30 | 75589.50 | $0.00 | 0.00 |
| 2009-06-30 | 43194.00 | $-0.02 | 0.00 |
| 2009-03-31 | 36714.90 | $-0.02 | 0.00 |
| 2008-12-31 | 47513.40 | $-0.02 | 0.00 |
| 2008-09-30 | 64791.00 | $-0.02 | 0.00 |
| 2008-06-30 | 86387.90 | $-0.04 | 0.00 |
| 2008-03-31 | 52912.60 | $-0.03 | 0.00 |
| 2007-12-31 | 58311.90 | $0.01 | 0.00 |
| 2007-09-30 | 77749.20 | $-0.02 | 0.00 |
| 2007-06-30 | 74509.60 | $0.01 | 0.00 |
| 2007-03-31 | 77749.20 | $0.02 | 4343530.73 |
| 2006-12-31 | 48593.20 | $-0.03 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.043B | $0.019B |
| Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.032B | 42.83 |
| Tempus AI (TEM) | United States | $12.162B | 0.00 |
| Doximity (DOCS) | United States | $7.681B | 31.63 |
| Hims & Hers Health (HIMS) | United States | $6.948B | 56.52 |
| IRhythm Holdings (IRTC) | United States | $5.309B | 0.00 |
| Hinge Health (HNGE) | United States | $3.288B | 0.00 |
| Privia Health (PRVA) | United States | $2.947B | 184.31 |
| 10x Genomics (TXG) | United States | $2.935B | 0.00 |
| Heartflow (HTFL) | United States | $2.853B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.348B | 38.85 |
| Omnicell (OMCL) | United States | $2.303B | 47.08 |
| Azenta (AZTA) | United States | $1.886B | 77.38 |
| Clover Health Investments (CLOV) | United States | $1.385B | 0.00 |
| Enovis (ENOV) | United States | $1.347B | 7.07 |
| Schrodinger (SDGR) | United States | $1.277B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.187B | 0.00 |
| Phreesia (PHR) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.871B | 0.00 |
| Talkspace (TALK) | United States | $0.658B | 132.33 |
| Standard BioTools (LAB) | United States | $0.619B | 0.00 |
| Claritev (CTEV) | United States | $0.497B | 0.00 |
| Evolent Health (EVH) | United States | $0.429B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.373B | 0.00 |
| Carlsmed (CARL) | United States | $0.352B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.326B | 0.00 |
| TruBridge (TBRG) | United States | $0.311B | 14.31 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| CapsoVision (CV) | United States | $0.293B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.263B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.196B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.191B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.167B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.163B | 0.00 |
| CareCloud (CCLD) | United States | $0.130B | 7.12 |
| Outset Medical (OM) | United States | $0.098B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.071B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.067B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.060B | 0.00 |
| 111 (YI) | China | $0.046B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.035B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.019B | 0.00 |
| Zhongchao (ZCMD) | China | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.011B | 0.00 |
| PROFUSA (PFSA) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |